Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

PLANET Onco Dose (3.2)

K-Number: K241765 · 2025-03-14

ApplicantDosisoft SA
Decision Date2025-03-14
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

PLANET Onco Dose (3.2) is a medical device manufactured by Dosisoft SA. It received FDA 510(k) clearance on 2025-03-14 under approval number K241765. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the PLANET Onco Dose (3.2)?

PLANET Onco Dose (3.2) is a medical device that received FDA 510(k) clearance on 2025-03-14. It is manufactured by Dosisoft SA. The 510(k) number is K241765.

When was PLANET Onco Dose (3.2) approved by the FDA?

PLANET Onco Dose (3.2) received FDA 510(k) clearance on 2025-03-14, under approval number K241765.

What company makes PLANET Onco Dose (3.2)?

PLANET Onco Dose (3.2) is manufactured by Dosisoft SA.

What is the FDA product code for PLANET Onco Dose (3.2)?

The FDA product code for PLANET Onco Dose (3.2) is LLZ.

Other Devices by Dosisoft SA

Related Devices (Code: LLZ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.